Divi's Laboratories

Divi's Laboratories

DIVISLAB

 ₹ 5,370.71
- ₹ 90.19
-1.65%
Modeled data

Divi's Laboratories  
Market Sentiment

TimelineReturnsVolume
Daily-1.65%6,00,916
Weekly4.87%34,30,590
Monthly18.28%87,44,910

Divi's Laboratories  
Performance

TimelineDailyWeeklyMonthly
DIVISLAB-1.65%4.87%18.28%
Index---
Peer Avg.-0.47%1.20%12.08%
*Avg of index constituents

Divi's Laboratories  
Fundamentals

TimelinePE PB EV/EBIDTA ROE ROCE Div. Yield
DIVISLAB39.579.9821.9228.1535.080.90
Index35.445.9816.8116.9918.411.19
Peer Avg.38.604.3513.4812.9616.490.78
*Avg of index constituents

Divi's Laboratories  
Key Metrics

MetricsSales GrowthProfit GrowthROE ROCE
FY '21-2229.59%50.02%28.15%35.08%
FY '20-2128.61%43.27%23.73%31.86%
FY '19-208.95%2.38%19.25%25.29%

Divi's Laboratories  
Shareholding Pattern

PromotersFIIDIIPublicOthers
Promoters : 51.94%
FII : 18.45%
DII : 18.32%
Public : 11.28%
Others : 0.01%

Divi's Laboratories  
Profit & Loss

MetricsSalesExpenditureEBITDA PAT
FY '21-228,919.835,041.893,992.912,954.49
FY '20-216,884.014,043.032,904.031,969.51
FY '19-205,352.493,532.682,009.561,374.62
All values are in crores

Divi's Laboratories  
Peer Comparison

MetricsSalesExpenditureEBITDA PAT
DIVISLAB8,919.835,041.893,992.912,954.49
CIPLA17,427.5613,488.354,433.432,624.43
SUNPHARMA27,120.2420,845.057,592.341,652.91
All values are in crores

Divi's Laboratories Share Price

Divi's Laboratories Limited is an Indian company that manufactures and markets active ingredients (APIs), intermediates and nutrients for export. The company's products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to its generic business, the Company supports pharmaceutical companies through custom synthesis businesses in the commercialization of their proprietary products, from gram-scale requirements for clinical trials to launch and late life cycle management. The company's subsidiaries are Divis Laboratories (USA) Inc and Divi's Laboratories Europe AG.

Divi's Laboratories FAQs

How to Buy Divi's Laboratories Share?

virtual
To purchase Divi's Laboratories shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Divi's Laboratories (ticker symbol: DIVISLAB) on the trading platform provided by your broker and purchase the shares.

What's Divi's Laboratories share price today?

virtual
The stock price of Divi's Laboratories as of 16 Sep 2024 is ₹5,370.71

What is the Market Cap of Divi's Laboratories?

virtual
Market capitalisation represents the total market value of a company's outstanding shares. As of 16 Sep 2024, Divi's Laboratories (ticker symbol: DIVISLAB) has a market capitalisation of approximately ₹8,89,82,41,33,302.00

What is the PE and PB ratio of Divi's Laboratories?

virtual
Divi's Laboratories Ltd's price-to-book ratio as of 16 Sep 2024 is 9.983163, reflecting the market's valuation compared to its asset value. As of 16 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 39.567066, indicating the market values the company at around ₹39.57 for every ₹1 of earnings

What is the 52 Week High and Low of Divi's Laboratories Share?

virtual
Divi's Laboratories Ltd (DIVISLAB) hit its 52-week high at ₹5,504.37, and its 52-week low at { ₹2,730.00}.
Data powered by Alphabet Inc.
Want to learn and earn in Stocks?
Login/Register
Start Learning